Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients

被引：0
|
作者：
Kim, H. [1 ]
Hong, J. [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70692-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S456 / S456
页数：1
相关论文
共 50 条
  • [11] Long-term treatment with long-acting risperidone in Korean patients with schizophrenia
    Lee, Moon-Soo
    Ko, Young-Hoon
    Lee, Sang-Hoon
    Seo, Yong-Jin
    Kim, Seung-Hyun
    Joe, Sook-Haeng
    han, Cg-Su Han
    Lee, Jung-Ho
    Jung, In-Kwa
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (06) : 399 - 407
  • [12] Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone
    Permuy, RT
    Turner, MS
    Bouhours, P
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 175 - 175
  • [13] Management of schizophrenia - Defining the role of long-acting injectable risperidone
    Curran, Monique P.
    Keating, Gillian M.
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2006, 14 (02) : 107 - 125
  • [14] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [15] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Mohamed, Somaia
    Rosenheck, Robert
    Harpaz-Rotem, Ilan
    Leslie, Douglas
    Sernyak, Michael J.
    PSYCHIATRIC QUARTERLY, 2009, 80 (04) : 241 - 249
  • [16] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Somaia Mohamed
    Robert Rosenheck
    Ilan Harpaz-Rotem
    Douglas Leslie
    Michael J. Sernyak
    Psychiatric Quarterly, 2009, 80 : 241 - 249
  • [17] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L
    Lam, A
    McCormick, J
    Luong, D
    Camacho, F
    VALUE IN HEALTH, 2005, 8 (06) : A202 - A203
  • [18] Cognitive improvements in patients with schizophrenia with risperidone long-acting injectable: Relationship to functioning?
    Pandina, G
    Bilder, R
    Harvey, P
    Lasser, RA
    Rodriguez, S
    Turkoz, I
    Gharabawi, G
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 500 - 500
  • [19] COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
    Dilla, T.
    O'Donohoe, P.
    Moeller, J.
    Alvarez, M.
    Sacristan, J.
    San, L.
    Happich, M.
    Tockhorn, A.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A292
  • [20] The cost-effectiveness of risperidone long-acting injectable in Sweden
    Damen, J.
    Heeg, B. M. S.
    Lothgren, M.
    Van Hout, B. A.
    VALUE IN HEALTH, 2007, 10 (06) : A293 - A294
12345